Abstract
Hepatic fibrosis in alcoholic liver disease often heralds progression to cirrhosis and, therefore, noninvasive parameters are required for early diagnosis and follow-up. Collagens VI and XIV, procollagen-III-N-propeptide, hyaluronic acid, and active transforming growth factor-β1 (TGF-β1) were measured in healthy volunteers, patients with alcoholic cirrhosis, and heavy drinkers without cirrhosis. Noncirrhotic alcoholics were assigned to two groups with either normal aspartate aminotransferase or levels ≥2 normal. Collagens VI and XIV were elevated in all alcoholic patients compared to controls (P < 0.0001, all instances). Procollagen-III-N-propeptide and hyaluronic acid levels were higher in alcoholic patients with elevated liver enzymes and in cirrhotics as compared to controls. Procollagen-III-N-propeptide revealed a significant correlation with serum levels of TGF-β1 (P < 0.0001). Collagens VI, and XIV, procollagen-III-N-propeptide, and hyaluronic acid appear to be sensitive markers indicating fibrotic transformation in alcoholics. The correlation between procollagen-III-N-propeptide and TGF-β1 emphasizes its role in hepatic fibrogenesis.
Similar content being viewed by others
REFERENCES
Lieber CS: Alcohol and the liver: 1994 Update. Gastroenterology 106:1085–1105, 1994
Sato S, Nouchi T, Worner TM, Lieber CS: Liver fibrosis in alcoholics. Detection by fab radioimmunoassay of serum procollagen III pepetides. JAMA 256:1471–1473, 1986
Schuppan D: Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glykoproteins. Semin Liver Dis 1:1–10, 1990
Schuppan D, Stoelzel U, Oesterling C, Somasundaram R: Serum assays for liver fibrosis. J Hepatol 22(suppl 2):82–88, 1995
Schuppan D, Strobel D, Hahn EG: Hepatic fibrosis- therapeutic strategies. Digestion 59:385–390, 1998
Bissell DM, Friedman SL, Maher JJ, Roll J: Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology 11:488–498, 1990
Schuppan D, Cantaluppi MC, Becker J, Veit J, Bunte T, Troyer D, Schuppan F, Schmid M, Ackermann R, Hahn EG: Undulin, an extracellular matrix glykoprotein associated with collagen fibrils. J Biol Chem 265:8823–8832, 1990
Milani S, Grappone C, Pellegrini G, Schuppan D, Herbst H, Calabro A, Casini A, Pinzani M, Surrenti C: Undulin RNA and protein expression in normal and fibrotic human liver. Hepatology 20:908–916, 1995
Gerling B, Becker M, Staab D, Schuppan D: Prediction of liver fibrosis according to serum collagen VI level in children with cystic fibrosis. N Engl J Med 22:1611–1612, 1997
Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen ER, Oesterling C, Abdel Raman HM, el Sahly AM, Abdel Razek SM, Seitz HK: Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 15:637–644, 1992
Shahin M, Schuppan D, Waldherr R, Savolainen ER, Salpur F, Rahman HM, el Sahly AM, Abdel Razek SM, el Ruby O, Seitz HK: Circulating enzyme activities of collagen turnover and undulin in patients with various degrees of schistosomiasis and alcoholic liver cirrhosis. Hepato-Gastroent 42:22–26, 1995
Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG: The integrated value of collagen type III over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 10:801–806, 1989
Annoni G, Colombo M, Cantaluppi MC, Khlat B, Lampertico P, Rojkind M: Serum Type III procollagen petide and laminin (lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 9:693–697, 1989
Niemalae O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H: Markers of fibrogenesis and basement membrane formation in alcoholic liver disease: Relation to severity, presence of hepatitis and alcohol intake. Gastroenterology 98:1612–1619, 1990
Murata K, Ochiai Y, Akashio K. Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis. Gastroenterology 89: 1248–1257, 1985
Gressner AM, Haarmann R: Regulation of hyaluronate synthesis in rat liver storing cells cultures by Kupffer cells. J Hepatol 7:310–318, 1988
Ramadori G, Zoehrens G, Manns MP, Rider H, Dienes HP, Hess G, Meyer-z. Bueschenfelde KH: Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 21:323–330, 1991
Pares A, Deulofeu A, Jimenez L, Caballeria U, Bruguera M, Caballeria J, Ballesta AM, Rodes J: Serum hyluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 24:1399–1403, 1996
Annoni G, Weiner FR, Zern MA: Increased transforming growth factor-β1 gene expression in human liver disease. J Hepatol 00:259–264, 1992
Milani S, Herbst H, Schuppan D: Transforming growth factors 1 and 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139:1221–1229, 1991
Friedman SL: The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 328:1828–1835, 1993
Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292, 1994
Orrego H, Israel Y, Blake JE, Medline A: Assessment of prognostic factors in alcoholic liver disease: towards a global quantitative expression of severity. Hepatology 3:896–905, 1983
Orrego H, Blake JE, Blendis LM, Israel Y: Prospective validation of the relationship of the combined clinical and laboratory index, the CCLI, with mortality in alcoholic liver disease. Hepatology 7:A1083, 1987
Schuppan D, Ruehlmann T, Hahn EG: Radioimmunoassay for human type VI collagen and ist application to tissue and body fluids. Anal Biochem 148:238–247, 1985
Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS: Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci 30: 1379–1384, 1982
Ehnis T, Dieterich W, Bauer M, von Lampe B, Schuppan D: A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res 229:388–397, 1996
Schuppan D: Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol 13(suppl 3):16–25, 1991
Casini A, Ceni E, Salzano R, Schuppan D, Milani S, Pellegrini G, Surrenti C: Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transforming growth factor β1: Comparison with fibronectin. Biochem Biophys Res Commun 199:1019–1026, 1994
Hayasaka A, Schuppan D, Ohnishi K, Okuda K, Hahn EG: Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. J Hepatol 10:17–22, 1990
Niemelae O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H: Connective tissue metabolism in alcoholic liver disease. Alcohol Alcoholism 00(suppl 1):351–355, 1991
Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26:643–649, 1997
Poeschl G, Strenge-Hesse A, Schuppan D, Stickel F, Simanowski UA, Seitz HK. Serum hyaluronate as an early indicator for altered connective tissue turnover in alcoholic liver disease. Gastroenterology 114A:1324, 1998
Bedossa P, Paradis V: Transforming growth factor-β(TGF-β): A key-role in liver fibrogenesis. J Hepatol 22(suppl 2):37–42, 1995
Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 85:1833–1843, 1990
Castilla A, Prieto J, Fausto N: TGF-β1 and TGF-β1; in chronic liver disease. Effects of interferon-a therapy. N Engl J Med 324:933–940, 1991
Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern MA: In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 108:2477–2482, 1989
Nagy P, Schaff Z, Lapis K: Immunohistochemical detection of TGF-β1 in fibrotic liver diseases. Hepatology 14:269–273, 1991
Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, et al: Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat storing cells. Gastroenterology 105:245–253, 1993
Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592–1598, 1993
Gao CF, Gressner G, Zoremba M, Gressner AM: Transforming growth factor b (TGF-β) expression in isolated and cultured rat hepatocytes. J Cell Physiol 167:394–405, 1996
Wahl S: Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 180:1587–1590, 1994
Gressner AM, Lotfi S, Gressner G, Haltner E, Kropf J: Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinosoidal cells). J Hepatol 19:117–132, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stickel, F., Urbaschek, R., Schuppan, D. et al. Serum Collagen Type VI and XIV and Hyaluronic Acid as Early Indicators for Altered Connective Tissue Turnover in Alcoholic Liver Disease. Dig Dis Sci 46, 2025–2032 (2001). https://doi.org/10.1023/A:1010616021659
Issue Date:
DOI: https://doi.org/10.1023/A:1010616021659